Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > new products are up including dark spot corrector

<< Previous

Bullboard Posts

Next >>

Post by jordanlundon Mar 09, 2021 7:13pm

177 Views

Post# 32756311

new products are up including dark spot corrector

https://www.rodanandfields.com/new-and-improved-regimens-and-dark-spot-corrector#cmsitem_00050083

"POTENT INGREDIENTS

ToneRF + patented RF3 Antioxidant Complex significantly minimize the visible size + intensity of stubborn dark spots + large dark patches for a more even-toned complexion."

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading